The Nicotinamide Adenine Dinucleotide market size is expected to reach $11.65 billion in 2030 at a CAGR of 15.8%, driven by longevity supplements
Read MoreThe Mental Well-Being Supplements Market is expected to reach $18.35 billion in 2030 at a CAGR of 11.1%, driven by personalized nutrition
Read MoreThe Longevity Supplements Market size is expected to reach $14.29 billion in 2030 at a CAGR of 10.2%, driven by personalized nutrition
Read MoreThe Lecanemab Injection Market size is expected to reach $6.63 billion in 2030 at a CAGR of 21.2%, driven by early diagnosis adoption
Read MoreThe Human Plasma Like Medium Market size is expected to reach $1.38 billion in 2030 at a CAGR of 8.6%, driven by rising demAnd for immunoglobulin therapies
Read MoreThe Gadolinium-Based Contrast Agents Market size is expected to reach $2.57 billion in 2030 at a CAGR of 6.4%, driven by rising diagnostic imaging demAnd
Read MoreThe blood–brain lymphatic drainage drug market is set for rapid growth, reaching $2.19B by 2030 at a 12.8% CAGR, driven by brain-targeted therapies And glymphatic system research.
Read MoreWorker heat stress monitoring wearable market to reach $1.04 billion by 2030 at 12.9% cagr, driven by growing need for real-time physiological monitoring.
Read MoreWearable ultrasound patches market to reach $1.93 billion by 2030 at 21.9% cagr, driven by increasing adoption of continuous non-invasive monitoring.
Read MoreWearable cardiac monitor patch market to reach $4.53 billion by 2030 at 17.2% cagr, driven by rising prevalence of cardiovascular diseases.
Read More